期刊文献+

血浆微小RNA-223及叉头框蛋白3a水平与冠心病患者心脏结构及功能的相关性研究 被引量:2

Correlation between plasma micro-223 and Forkhead Box 3a levels and cardiac structural changes in coronary heart disease patients
下载PDF
导出
摘要 目的探讨血浆微小RNA-223(miR-223)及叉头框蛋白3a(FoxO3a)水平与冠心病患者心脏结构变化的相关性。方法纳入2019年1月至2020年12月在新疆医科大学第一附属医院住院的126例冠心病患者为研究组和111例非冠心病患者为对照组,平均年龄(66.38±12.12)岁比(49.35±9.60)岁。通过酶联免疫分析法,检测所有研究对象血浆miR-223及FoxO3a水平,分析其与超声心动图中左心房(LA)、右心房(RA)、左心室舒张末期容积(EDV)、左心室收缩末期容积(ESV)、室间隔、右心室流出道、右心室(RV)、肺动脉、室壁运动评分、MV-E、MV-A、MV-E/A和射血分数(EF)等指标的关系。结果两组在年龄、合并高血压方面差异具有统计学意义(t=6.954、χ^(2)=12.014,P=0.000、0.001)。研究组miR-223[(0.415±0.065)ng/L比(0.309±0.057)ng/L]、FoxO3a[(0.402±0.058)ng/L比(0.306±0.059)ng/L]水平明显高于对照组,且差异具有统计学意义(P<0.05)。相关分析中,miR-223和FoxO3a水平间呈正相关(r=0.485,P=0.000)。miR-223和FoxO3a水平与冠心病之间,年龄成为控制变量后仍呈相关性(r=0.388,P=0.000;r=0.506,P=0.000)。miR-223水平与心脏超声各指标中与LA、EDV、ESV、RA、室壁运动评分呈正相关(r=0.358、0.338、0.339、0.282、0.274,P=0.001、0.002、0.002、0.012、0.015)。FoxO3a水平与超声心动图各指标中与LA、EDV、ESV、室壁运动评分呈正相关(r=0.302、0.312、0.380、0.373,P=0.007、0.005、0.001、0.001),与FE呈负相关(r=-0.278,P=0.013)。结论血浆miR-223、FoxO3a水平在冠心病患者中明显升高,呈高表达状态,并与冠心病患者发生心脏结构的变化有一定的相关性。 Objective To investigate the correlation between plasma miR-223 and Forkhead box 3 a(FoxO3 a)levels and cardiac structural changes in elderly patients with coronary heart disease.Methods From January 2019 to December 2020,126 patients with coronary heart disease and 111 individuals without coronary heart disease in the First Affiliated Hospital of Xinjiang Medical University were enrolled as study group and control group,with an average age of(66.38±12.12)years vs.(49.35±9.60)years old.The levels of miR-223 and FoxO3 a were detected by enzyme-linked immunosorbent assay(ELISA).The relationship between plasma miR-223 and FoxO3 a with the left atrium(LA),right atrium(RA),left ventricular end diastolic volume(EDV),left ventricular end systolic volume(ESV),interventricular septum(IVS),right ventricular outflow tract(RVOT),right ventricular(RV),pulmonary artery pressure(PAP),color kinesis(CK),diastolic mitral antegrade flow peak E(MV-E),diastolic mitral antegrade flow peak A(MV-A),and ejection fraction(EF)were analyzed.Results There were significant differences in age and hypertension between the two groups(t=6.954,χ^(2)=12.014,P=0.000,0.001 respectively).In the study group,mi R-223[(0.415±0.065)ng/L vs.(0.309±0.057)ng/L]and Fox O3 a[(0.402±0.058)ng/L vs.(0.306±0.059)ng/L]were significantly higher than the control group,and the difference was statistically significant(P<0.05).There was a positive correlation between the levels of mi R-223 and Fox O3 a(r=0.485,P=0.000).The correlation between the levels of mi R-223 and Fox O3 a with coronary heart disease still remained significant after the age became the control variable(r=0.388,P=0.000;r=0.506,P=0.000).The level of mi R-223 was positively correlated with LA,EDV,ESV,RA and CK(r=0.358,0.338,0.339,0.282,0.274,P=0.001,0.002,0.002,0.012,0.015).Fox O3 a level was positively correlated with LA,EDV,ESV and CK(r=0.302,0.312,0.373,P=0.007,0.005,0.001),and negatively correlated with EF(r=-0.275,-0.278,P=0.014,0.013).Conclusion The plasma levels of mi R-223 and Fox O3 a both are significantly increased in the patients with coronary heart disease,showing a high expression state,and have a certain correlation with the changes of the cardiac structure.
作者 沙吉旦·阿不都热衣木 高颖 邢智 李辉 刘莎莎 帕丽达·阿布来提 ABUDUREYIMU Shajidan;GAO Ying;XING Zhi;LI Hui;LIU Sha-sha;ABULAITI Palida(Comprehensive Internal Medicine Department,The First Affiliated Hospital of Xinjiang Medical University,Urumqi 830011,China)
出处 《中国心血管病研究》 CAS 2022年第3期214-219,共6页 Chinese Journal of Cardiovascular Research
基金 新疆维吾尔自治区区域协同创新专项(科技援疆计划)(2020E02131)。
关键词 血浆微小RNA-223 叉头框蛋白3a 冠心病 心脏超声 miR-223 Forkhead box 3a Coronary heart disease Cardiac ultrasound structure
  • 相关文献

参考文献3

二级参考文献17

  • 1郑哲,胡盛寿,周玉燕.非体外循环和体外循环下冠状动脉旁路移植术后早中期结果比较[J].中国循环杂志,2005,20(4):300-301. 被引量:6
  • 2Hannan EL, Racz MJ, Walfnrd G, et al. Long-term outonles of coronary-artery bypass grafting versus stent implantation. N Engl J Med, 2005, 352: 2174-2183.
  • 3Hannan EL, Wu C, Walfurd G, et al. Drug-eluting stents vs. coronary- artery bypass grafting in multivessel coronary disease. N Engl J Med, 2008, 358: 331-341.
  • 4Hannan EL, Racz MJ, Gold J, et al. Adherence of cathete,'izatinn laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coronary artery bypass graft surgery: what happens in actual practice'? Circulation, 2010, 121: 267-275.
  • 5Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Fnrce on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation, 2004, 110: e340-437.
  • 6Smith SC Jr, Fehlman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 Guideline Update tbr Percutaneous Coronary lntervention-sununary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines tbr Percutaneous Coronary Intervention). Circulation, 2006, 113: 156-175.
  • 7Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practi'e Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation, 2011, 124: 2574-2609.
  • 8Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Cuidcline for Coronary Artery Bypass f;raft Surgery: executive summary: a report of tile American College of Cardiology Foundation/American Hearl Association Task Foree on Practice Guidelines. Circulation, 2011, 124: 2610-2642.
  • 9Hannan EL, Samadashvili Z, Walfird G, at al. Predictors and outcomes of ad hoc versus non-ad hoc pereutaneous coronary interventions. JACC Cardiovasc Interv, 2009, 2: 350-356.
  • 10Nallamothu BK, Krumholz HM. Putting ad hoc PCI on pause. JAMA, 2010, 304: 2059-2060.

共引文献51

同被引文献26

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部